Diabetes Retinopathy – What It Is? An Ayurveda Perspective
Diabetic Retinopathy: An Ayurvedic Perspective
Table of Contents
Introduction
Diabetic retinopathy is one of the most common complications of diabetes, affecting the blood vessels in the retina and leading to vision impairment or even blindness if left untreated (American Diabetes Association, 2022). Persistently high blood sugar levels damage the delicate blood vessels in the retina, causing swelling, leakage, or abnormal vessel growth (Jones, 2020). While modern medicine primarily addresses the condition through surgery and medications, Ayurveda offers a holistic approach to managing diabetic retinopathy by addressing its root causes and enhancing overall eye health (Chauhan, 2021).
At the Diabetes Reversal Clinic, under the expert guidance of Dr. Soumya Hullanavar, we specialize in Ayurvedic management of diabetic complications, including retinopathy, through personalized care aimed at long-term recovery and prevention (EliteAyurveda, 2023).
Understanding Diabetic Retinopathy
Stages of Diabetic Retinopathy
| Stage | Description |
|---|---|
| Mild Non-Proliferative Retinopathy | Early stage with microaneurysms (tiny bulges in retinal blood vessels) (American Academy of Ophthalmology, 2021). |
| Moderate Non-Proliferative Retinopathy | Progression with blocked blood vessels and retinal swelling (American Academy of Ophthalmology, 2021). |
| Severe Non-Proliferative Retinopathy | More blood vessels are blocked, depriving the retina of oxygen and triggering abnormal vessel growth (American Academy of Ophthalmology, 2021). |
| Proliferative Diabetic Retinopathy | Advanced stage with abnormal blood vessels, risk of bleeding into the eye, and retinal detachment (American Academy of Ophthalmology, 2021). |
Symptoms of Diabetic Retinopathy
- Blurred or fluctuating vision (Jones, 2020).
- Floaters or dark spots in vision (Jones, 2020).
- Difficulty seeing in low light (Jones, 2020).
- Sudden vision loss in advanced cases (American Diabetes Association, 2022).
Ayurvedic Insights on Diabetic Retinopathy
Ayurveda identifies diabetic retinopathy as a result of aggravated Pitta dosha and toxin (Ama) accumulation in the blood channels of the eyes (Rakta Srotas) (Gupta & Singh, 2017). The imbalance disrupts proper blood flow and nourishment to the retina, leading to degeneration.
Key Ayurvedic Concepts
- Pitta Aggravation: Heat and inflammation damage the delicate tissues of the eyes (Chauhan, 2021).
- Toxin Accumulation (Ama): Blocks blood flow and hampers oxygen supply (Gupta & Singh, 2017).
- Weakened Agni (Digestive Fire): Impairs nutrient absorption, affecting eye health (Sharma, 2018).
Ayurvedic Management of Diabetic Retinopathy
1. Detoxification and Toxin Removal
- Therapies: Ayurvedic detox techniques help eliminate Ama and improve blood flow to the eyes (Chauhan, 2021).
- Dietary Practices: Bitter vegetables like bitter gourd and neem are used to detoxify blood channels (Gupta & Singh, 2017).
2. Cooling Therapies to Pacify Pitta
- Herbal Applications: Use of medicated ghee, rose water, and cooling eye drops (Gupta & Singh, 2017).
- Dietary Adjustments: Include cooling foods like cucumber, amla, and coriander (Sharma, 2018).
3. Eye Nourishment
- Antioxidant Herbs: Triphala is widely used to strengthen the eyes and prevent degeneration (Chauhan, 2021).
- Nutritional Support: Foods rich in vitamin A, lutein, and zeaxanthin support retinal health (American Diabetes Association, 2022).
4. Lifestyle Modifications
- Stress Management: Meditation and pranayama to reduce oxidative stress (Sharma, 2018).
- Screen Time Reduction: Limiting exposure to digital screens to prevent strain (Gupta & Singh, 2017).
Comparison of Ayurveda and Allopathy for Diabetic Retinopathy
| Aspect | Ayurveda | Allopathy |
|---|---|---|
| Focus | Addresses root causes by balancing doshas and detoxifying the body (Chauhan, 2021). | Focuses on symptom management and halting progression (American Academy of Ophthalmology, 2021). |
| Treatments | Detox therapies, herbal medications, and dietary changes (Gupta & Singh, 2017). | Laser therapy, anti-VEGF injections, and surgery (American Academy of Ophthalmology, 2021). |
| Sustainability | Promotes long-term eye health by addressing systemic issues (Sharma, 2018). | Effective for acute management but may require repeated interventions (Jones, 2020). |
Case Studies at the Diabetes Reversal Clinic
Case 1: Vision Improvement in Advanced Retinopathy
- Patient Profile: A 60-year-old male with proliferative diabetic retinopathy (EliteAyurveda, 2023).
- Ayurvedic Approach: Detox therapies, Triphala ghee application, and dietary changes (EliteAyurveda, 2023).
- Outcome: Significant improvement in vision clarity and reduced retinal swelling after 3 months (EliteAyurveda, 2023).
Case 2: Early-Stage Retinopathy Reversal
- Patient Profile: A 45-year-old female with mild retinopathy (EliteAyurveda, 2023).
- Ayurvedic Approach: Herbal formulations, stress management, and Pitta-pacifying foods (EliteAyurveda, 2023).
- Outcome: Normalized retinal blood flow and prevention of progression (EliteAyurveda, 2023).
Practical Tips for Managing Diabetic Retinopathy
- Control Blood Sugar: Regularly monitor glucose levels and maintain a balanced diet (American Diabetes Association, 2022).
- Incorporate Antioxidants: Include foods like amla, carrots, and spinach for eye nourishment (Sharma, 2018).
- Practice Eye Exercises: Simple techniques like palming and blinking to relieve eye strain (Jones, 2020).
- Avoid Pitta-Aggravating Foods: Spicy, fried, and processed foods should be minimized (Gupta & Singh, 2017).
- Consult an Ayurvedic Expert: Personalized guidance is key for effective management (EliteAyurveda, 2023).
From the Doctor’s Desk
Dr. Soumya Hullanavar shares her insights:
“Diabetic retinopathy is not just a localized eye condition; it reflects systemic imbalances caused by diabetes. Ayurveda provides a unique advantage by addressing the root cause, improving overall blood circulation, and promoting retinal health. Our approach integrates detox therapies, dietary modifications, and personalized care to help patients regain and protect their vision” (Hullanavar, 2023).
Why Choose the Diabetes Reversal Clinic?
- Personalized Ayurvedic Care: Tailored treatments based on individual constitution and condition (EliteAyurveda, 2023).
- Comprehensive Management: Addressing both diabetes and its complications holistically (Gupta & Singh, 2017).
- Expert Guidance: Led by Dr. Soumya Hullanavar, a specialist in Ayurvedic endocrinology (Hullanavar, 2023).
- Sustainable Outcomes: Focus on long-term eye health and diabetes reversal (Sharma, 2018).
Take Control of Your Vision Today
Diabetic retinopathy can be managed and even reversed with the right approach. At the Diabetes Reversal Clinic, we combine ancient Ayurvedic wisdom with modern insights to provide holistic, effective care (EliteAyurveda, 2023).
📞 Contact us today: +91 8884722267
🌐 Visit: Diabetes Reversal Clinic
Rediscover balance, vitality, and health with Ayurveda!
Related-
Know more about Ayurveda Diabetes Reversal Treatments.
GET IN TOUCH
Schedule a Visit
References
References
Maurya, R.P. Diabetic retinopathy: My brief synopsis. Indian J. Clin. Exp. Ophthalmol. 2015, 1, 189–190. [Google Scholar]
Song, P.; Yu, J.; Chan, K.Y.; Theodoratou, E.; Rudan, I. Prevalence, risk factors and burden of diabetic retinopathy in China: A systematic review and meta-analysis. J. Glob. Health 2018, 8, 010803. [Google Scholar] [CrossRef] [PubMed]
Watkins, P.J. Retinopathy. Br. Med. J. 2003, 326, 924–926. [Google Scholar] [CrossRef] [PubMed]
Fowler, M.J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes 2008, 26, 77–82. [Google Scholar] [CrossRef] [Green Version]
Porta, M.; Bandello, F. Diabetic retinopathy. Diabetologia 2002, 45, 1617–1634. [Google Scholar] [CrossRef] [Green Version]
Fong, D.S.; Aiello, L.; Gardner, T.W.; King, G.L.; Blankenship, G.; Cavallerano, J.D.; Ferris, F.L.; Klein, R. Retinopathy in diabetes. Diabetes Care 2004, 27, s84–s87. [Google Scholar] [CrossRef]
Stitt, A.W.; Curtis, T.M.; Chen, M.; Medina, R.J.; McKay, G.J.; Jenkins, A.; Gardiner, T.A.; Lyons, T.J.; Hammes, H.P.; Simo, R.; et al. The progress in understanding and treatment of diabetic retinopathy. Prog. Retin. Eye Res. 2016, 51, 156–186. [Google Scholar] [CrossRef] [PubMed]
Raman, R.; Gella, L.; Srinivasan, S.; Sharma, T. Diabetic retinopathy: An epidemic at home and around the world. Indian J. Ophthalmol. 2016, 64, 69. [Google Scholar] [CrossRef]
Aiello, L.M. Perspectives on diabetic retinopathy. Am. J. Ophthalmol. 2003, 136, 122–135. [Google Scholar] [CrossRef]
Wang, W.; Lo, A. Diabetic Retinopathy: Pathophysiology and Treatments. Int. J. Mol. Sci. 2018, 19, 1816. [Google Scholar] [CrossRef] [Green Version]
Madsen-Bouterse, S.A.; Kowluru, R.A. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Rev. Endocr. Metab. Disord. 2008, 9, 315–327. [Google Scholar] [CrossRef] [PubMed]
Duh, E.J.; Sun, J.K.; Stitt, A.W. Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. J. Clin. Investig. 2017, 2, e93751. [Google Scholar] [CrossRef] [PubMed]
Shani, M.; Eviatar, T.; Komaneshter, D.; Vinker, S. Diabetic Retinopathy –Incidence and Risk Factors in A Community Setting- A Longitudinal Study. Scand. J. Prim. Health Care 2018, 36, 237–241. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Davidson, J.A.; Ciulla, T.A.; McGill, J.B.; Kles, K.A.; Anderson, P.W. How the diabetic eye loses vision. Endocrine 2007, 32, 107–116. [Google Scholar] [CrossRef]
Ola, M.S.; Nawaz, M.I.; Siddiquei, M.M.; Al-Amro, S.; Abu El-Asrar, A.M. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J. Diabetes Complicat. 2012, 26, 56–64. [Google Scholar] [CrossRef]
Yamagishi, S.; Matsui, T.; Inoue, H. Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells. Drugs Exp. Clin. Res. 2005, 31, 227–232. [Google Scholar]
Yamagishi, S.; Matsui, T.; Nakamura, K.; Takeuchi, M.; Imaizumi, T. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukocytosis. Microvasc. Res. 2006, 72, 86–90. [Google Scholar] [CrossRef]
Yamagishi, S.; Matsui, T. Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy. Curr. Pharm. Biotechnol. 2011, 12, 362–368. [Google Scholar] [CrossRef]
Ibrahim, A.S.; El-Remessy, A.B.; Matragoon, S.; Zhang, W.; Patel, Y.; Khan, S.; Al Gayyer, M.M.; El-Shishtawy, M.M.; Liou, G.I. Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes. Diabetes 2011, 60, 1122–1133. [Google Scholar] [CrossRef] [Green Version]
Calderon, G.; Juarez, O.; Hernandez, G.; Punzo, S.; De la Cruz, Z. Oxidative stress and diabetic retinopathy: Development and treatment. Eye 2007, 31, 1122–1130. [Google Scholar] [CrossRef] [PubMed]
Lorenzi, M. The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient. Exp. Diabetes Res. 2007, 2007, 1–10. [Google Scholar] [CrossRef] [PubMed]
Van den Enden, M.K.; Nyengaard, J.R.; Ostrow, E.; Burgan, J.H.; Williamson, J.R. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism, Implications for diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 1995, 36, 1675–1685. [Google Scholar]
Steinmetz, P.R.; Balko, C.; Gabbay, K.H. The Sorbitol Pathway and the Complications of Diabetes. N. Engl. J. Med. 1973, 288, 831–836. [Google Scholar] [CrossRef] [PubMed]
Szwergold, B.; Kappler, F.; Brown, T. Identification of fructose 3-phosphate in the lens of diabetic rats. Science 1990, 247, 451–454. [Google Scholar] [CrossRef]
Gonzalez, R.G.; Miglior, S.; Von Saltza, I.; Buckley, L.; Neuringer, J.; Cheng, H.-M. 31P NMR studies of the diabetic lens. Magn. Reson. Med. 1988, 435–444. [Google Scholar] [CrossRef]
Ido, Y.; Kilo, C.; Williamson, J.R. Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 1997, 40, S115–S117. [Google Scholar] [CrossRef] [Green Version]
Drel, V.R.; Xu, W.; Zhang, J.; Kador, P.F.; Ali, T.K.; Shin, J.; Julius, U.; Slusher, B.; El-Remessy, A.B.; Obrosova, I.G. Poly (ADP-Ribose) Polymerase Inhibition Counteracts Cataract Formation and Early Retinal Changes in Streptozotocin-Diabetic Rats. Investig. Ophthalmol. Vis. Sci. 2009, 50, 1778. [Google Scholar] [CrossRef]
Engerman, R.L.; Kern, T.S. Hyperglycemia as a cause of diabetic retinopathy. Metabolism 1986, 35, 20–23. [Google Scholar] [CrossRef]
Holman, R.R.; Paul, S.K.; Bethel, M.A.; Matthews, D.R.; Neil, H.A.W. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008, 359, 1577–1589. [Google Scholar] [CrossRef] [Green Version]
Reiter, C. Functions of insulin and insulin receptor signaling in retina: Possible implications for diabetic retinopathy. Prog. Retin. Eye Res. 2003, 22, 545–562. [Google Scholar] [CrossRef]
Ferguson, T.A.; Griffith, T.S. A vision of cell death: Insights into immune privilege. Immunol. Rev. 1997, 156, 167–184. [Google Scholar] [CrossRef]
James, C.R.; Cotlier, E. Fate of insulin in the retina: An autoradiographic study. Br. J. Ophthalmol. 1983, 67, 80–88. [Google Scholar] [CrossRef] [Green Version]
Folli, F.; Bonfanti, L.; Renard, E.; Kahn, C.; Merighi, A. Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J. Neurosci. 1994, 14, 6412–6422. [Google Scholar] [CrossRef]
Baskin, D.G.; Sipols, A.J.; Schwartz, M.W.; White, M.F. Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: Colocalization with phosphotyrosine. Regul. Pept. 1993, 48, 257–266. [Google Scholar] [CrossRef]
Zetterstrom, C.; Benjamin, A.; Rosenzweig, S.A. Differential Expression of Retinal Insulin Receptors in STZ-Induced Diabetic Rats. Diabetes 1992, 41, 818–825. [Google Scholar] [CrossRef]
Gardner, T.W.; Antonetti, D.A.; Barber, A.J.; Lanoue, K.F.; Nakamura, M. New insights into the pathophysiology of diabetic retinopathy: Potential cell-specific therapeutic targets. Diabetes Technol. Ther. 2000, 2, 601–608. [Google Scholar] [CrossRef]
